Search

Home > GRACEcast Lung Cancer Video > Choices Among Immunotherapeutics May Be the Future of Lung Cancer Care
Podcast: GRACEcast Lung Cancer Video
Episode:

Choices Among Immunotherapeutics May Be the Future of Lung Cancer Care
Category: Science & Medicine
Duration: 00:06:02
Publish Date: 2015-06-25 14:00:00
Description:

Novel immunotherapy agent atezolizumab (MPDL3280A) looks superior to Taxotere (docetaxel) in a study, specifically for patients with PD-L1. What are the implications of multiple agents with similar mechanisms of action in the same clinical settings?
Total Play: 0